Have a feature idea you'd love to see implemented?
Let us know!
ATNF 180 Life Sciences Corp
Price (delayed)
$3.88
Market cap
$3.76M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$15.88
Enterprise value
$3.06M
180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined
Highlights
ATNF's EPS has surged by 96% year-on-year and by 46% since the previous quarter
180 Life Sciences's net income has surged by 76% YoY and by 23% QoQ
180 Life Sciences's equity has plunged by 106% YoY but it has soared by 56% from the previous quarter
The quick ratio has surged by 71% since the previous quarter but it has declined by 38% year-on-year
Key stats
What are the main financial stats of ATNF
Market
Valuations
Earnings
Shares outstanding
969,602
Market cap
$3.76M
Enterprise value
$3.06M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$14.85M
EBITDA
-$14.75M
Free cash flow
-$4.24M
Per share
Balance sheet
Liquidity
EPS
-$15.88
Free cash flow per share
-$4.61
Book value per share
-$0.44
Revenue per share
$0
TBVPS
$2.55
Total assets
$3.91M
Total liabilities
$4.33M
Debt
$442,285
Equity
-$417,987
Working capital
-$1.67M
Debt to equity
-1.06
Current ratio
0.58
Quick ratio
0.29
Net debt/EBITDA
0.05
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-285.7%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ATNF stock price
How has the 180 Life Sciences stock price performed over time
Intraday
-8.71%
1 week
-10.39%
1 month
107.49%
1 year
-53.42%
YTD
-4.43%
QTD
132.34%
Financial performance
How have 180 Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$8.93M
Net income
-$12.55M
Gross margin
N/A
Net margin
N/A
180 Life Sciences's net income has surged by 76% YoY and by 23% QoQ
180 Life Sciences's operating income has surged by 51% YoY and by 17% QoQ
Growth
What is 180 Life Sciences's growth rate over time
Valuation
What is 180 Life Sciences stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ATNF's EPS has surged by 96% year-on-year and by 46% since the previous quarter
180 Life Sciences's equity has plunged by 106% YoY but it has soared by 56% from the previous quarter
Efficiency
How efficient is 180 Life Sciences business performance
The company's return on assets fell by 20% QoQ and by 14% YoY
Dividends
What is ATNF's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ATNF.
Financial health
How did 180 Life Sciences financials performed over time
The company's total assets is 10% lower than its total liabilities
The quick ratio has surged by 71% since the previous quarter but it has declined by 38% year-on-year
The company's total assets has shrunk by 71% YoY but it rose by 14% QoQ
180 Life Sciences's equity has plunged by 106% YoY but it has soared by 56% from the previous quarter
ATNF's debt is down by 44% since the previous quarter and by 28% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.